
SPECIAL YEAR-END ADVOCACY ALERT
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
Assorted News from the Last Week: The simple act of asking young patients about their symptoms regularly during cancer treatment can help them get more
During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
Assorted News from the Last Week: CAC2 Individual Member Jennifer Flowers writes compellingly about “When the National Drug Shortage Becomes Personal” for her. Published in
By CAC2 Individual Member Jennifer Flowers Rhabdomyosarcoma became a common word in my family when I was three years old. By the time of diagnosis,
Assorted News from the Last Week: Last week the FDA reported that it is investigating reports of blood cancers — including life-threatening cases of myelodysplastic
Assorted News from the Last Week: In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
Assorted News from the Last Week: Electronic symptom screening in kids with cancer boosts quality of care. DIPG Research in Nature: brain tumor yields, in
By CAC2 Student Member Joshua Omale Attending the 2024 International Cancer Week, organized by Nigeria’s National Institute for Cancer Research and Treatment (NICRAT), was indeed